BackIgene Biotechnology Overview

Igene Biotechnology Common Stock

Igene Biotechnology's common stock is $16M.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$15.65M
↑ 0.32% YoYΔ $50000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Igene Biotechnology Common Stock History

Loading

Igene Biotechnology vs. peers: Common Stock Comparison

Loading

Igene Biotechnology Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Igene Biotechnology (IGNE) FAQ

As of the most recent data (September 2010), IGNE shows a common stock of $16M. That compares with $16M in the prior-year period — up 0.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IGNE's common stock is now $16M (was $16M) — a 0.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Igene Biotechnology is outperforming or lagging.

Tracking IGNE's common stock over time shows whether Igene Biotechnology is scaling, shrinking, or reshaping that part of the business. The current reading is $16M That compares with $16M in the prior-year period — up 0.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Igene Biotechnology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $16M) with ownership activity and broader fundamentals.